DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
13F holders, Q3 2022
Institutional positions in DBV Technologies S.A. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q2 2022
- Shares held
- 34.5M
- +8.59M (+33.1%) vs. Q2 2022
- Total value
- $61.1M
- −$5.63M (−8.4%) vs. Q2 2022
- New holders
- 7
- 6 more added
- Sold out
- 8
- 9 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $345.7M |
| Q1 2026 | 71 | $433.6M |
| Q4 2025 | 52 | $302.1M |
| Q3 2025 | 33 | $65.2M |
| Q2 2025 | 29 | $66.2M |
| Q1 2025 | 16 | $16.8M |
| Q4 2024 | 18 | $8.46M |
| Q3 2024 | 24 | $11.3M |
| Q2 2024 | 30 | $13.7M |
| Q1 2024 | 33 | $29.2M |
| Q4 2023 | 40 | $36.6M |
| Q3 2023 | 38 | $60.4M |
| Q2 2023 | 36 | $87.4M |
| Q1 2023 | 34 | $71.3M |
| Q4 2022 | 38 | $68.0M |
| Q3 2022 | 36 | $61.1M |
| Q2 2022 | 38 | $66.8M |
| Q1 2022 | 31 | $32.9M |
| Q4 2021 | 41 | $34.7M |
| Q3 2021 | 51 | $179.8M |
| Q2 2021 | 48 | $243.5M |
| Q1 2021 | 44 | $197.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding DBV Technologies S.A.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 14,614,264 | $25.9M | 0.17% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 7,064,964 | $12.5M | 2.31% | +2,233,809+46.2% | Added |
| Ra Capital Management, L.P. | 3,724,740 | $6.59M | 0.14% | +3,724,740 | New |
| Vivo Capital, LLC | 2,708,875 | $4.79M | 0.53% | +2,708,875 | New |
| Boxer Capital, LLC | 2,134,598 | $3.78M | 0.21% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 1,294,198 | $2.29M | 0.00% | −2,399−0.2% | Reduced |
| BlackRock Inc. | 1,042,531 | $1.84M | 0.00% | −25,931−2.4% | Reduced |
| Millennium Management LLC | 566,434 | $1.00M | 0.00% | +566,434 | New |
| Morgan Stanley | 531,759 | $941.0K | 0.00% | −44,780−7.8% | Reduced |
| Nan Fung Group Holdings Ltd | 370,950 | $657.0K | 0.42% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 181,050 | $320.0K | 0.00% | +42,928+31.1% | Added |
| BNP Paribas Arbitrage, SA | 57,899 | $102.5K | 0.00% | +38,812+203.3% | Added |
| Cowen and Company, LLC | 50,986 | $90.0K | 0.01% | −109,778−68.3% | Reduced |
| Envestnet Asset Management Inc | 38,028 | $67.0K | 0.00% | +38,028 | New |
| Two Sigma Investments, LP | 35,920 | $64.0K | 0.00% | +16,066+80.9% | Added |
| Janney Montgomery Scott LLC | 25,700 | $45.0K | 0.00% | −4,000−13.5% | Reduced |
| Geode Capital Management, LLC | 23,666 | $41.0K | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 20,172 | $36.0K | 0.00% | +20,172 | New |
| Commonwealth Equity Services, LLC | 14,700 | $26.0K | 0.00% | +14,700 | New |
| Goldman Sachs Group Inc | 14,400 | $25.0K | 0.00% | 00.0% | Unchanged |
| Heritage Wealth Advisors | 6,000 | $10.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,992 | $9.00K | 0.00% | −2,039−29.0% | Reduced |
| Federation des caisses Desjardins du Quebec | 4,255 | $7.53K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,309 | $7.00K | 0.00% | +4,309 | New |
| Group One Trading, L.P. | 2,826 | $5.00K | 0.00% | −8,300−74.6% | Reduced |
| Cutler Group LP | 3,100 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,844 | $3.00K | 0.00% | −2,286−55.4% | Reduced |
| Wells Fargo & Company | 1,861 | $3.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 891 | $2.00K | 0.00% | +607+213.7% | Added |
| Advisor Group Holdings, Inc. | 855 | $1.00K | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Annapolis Financial Services, LLC | 270 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 65 | $0 | 0.00% | −10−13.3% | Reduced |
| Royal Bank of Canada | 296 | $0 | 0.00% | +193+187.4% | Added |
| TCI Wealth Advisors, Inc. | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −316,939−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −183,867−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −51,584−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −32,861−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −14,713−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |